Amortization of acquired intangible assets for 1Q FY2009 was RMB49.8 million (US$7.3 million), of which RMB22.4 million was allocated to cost of revenues and RMB27.4 million to general and administrative expenses.
As of June 30, 2009, the Company's cash balance was RMB1,547.5 million (US$226.6 million). Net operating cash flow for 1Q FY2009 was RMB94.3 million (US$13.8 million).
As of June 30, 2009, the Company's net accounts receivable was RMB346.9 million (US$50.8 million), representing an increase of 1.1% from the balance at March 31, 2009.
For the convenience of readers, certain RMB amounts have been translated into U.S. dollars at the rate of RMB6.8302 to US$1.00, the noon buying rate in New York City for cable transfers of RMB per U.S. dollar as set forth in the H.10 weekly statistical release of the Federal Reserve Board, as of Tuesday, June 30, 2009.
Outlook for 2Q FY2009
Due to the uncertainties relating to various aspects of the Company's businesses, the Company is only able to provide the target revenues from continuing operations for the second fiscal quarter ending September 30, 2009 ("2Q FY2009"). The target revenues from continuing operations for 2Q FY2009 range from RMB165.0 million (US$24.2 million) to RMB180.0 million (US$26.4 million).
The above targets are based on the Company's current views on the operating and marketing conditions, which are subject to change.
New Management Appointment
The nomination committee and the board of directors of the Company have
approved the promotion of Mr. Charles Zhu to the position of Senior Vice
President - Operations effective October 1, 2009. Mr. Zhu has been working as
Vice President - Business Development of the Company since January 2005 and
|SOURCE China Medical Technologies, Inc.|
Copyright©2009 PR Newswire.
All rights reserved